TY - JOUR
T1 - Critical analysis of Strattice performance in complex abdominal wall reconstruction
T2 - Intermediate-risk patients and early complications
AU - Patel, Ketan M.
AU - Albino, Frank P.
AU - Nahabedian, Maurice Y.
AU - Bhanot, Parag
PY - 2013
Y1 - 2013
N2 - The purpose of this study was to analyze the performance of a porcine-derived acellular dermal matrix (Strattice Reconstructive Tissue Matrix) in patients at increased risk for perioperative complications. We reviewed medical records for patients with complex abdominal wall reconstruction (AWR) and Strattice underlay from 2007 to 2010. Intermediate-risk patients were defined as having multiple comorbidities without abdominal infection. Forty-one patients met the inclusion criteria (mean age, 60 years; mean body mass index, 35.5 kg/m2). Comorbidities included coronary artery disease (63.4%), diabetes mellitus (36.6%), and chronic obstructive pulmonary disease (17.1%). Fascial closure was achieved in 40 patients (97.6%). Average hospitalization was 6.4 days (range, 1-24 days). Complications included seroma (7.3%), wound dehiscence with Strattice exposure (4.9%), cellulitis (2.4%), and hematoma (2.4%). All patients achieved abdominal wall closure with no recurrent hernias or need for Strattice removal. Patients with multiple comorbidities at intermediate risk of postoperative complications can achieve successful, safe AWR with Strattice.
AB - The purpose of this study was to analyze the performance of a porcine-derived acellular dermal matrix (Strattice Reconstructive Tissue Matrix) in patients at increased risk for perioperative complications. We reviewed medical records for patients with complex abdominal wall reconstruction (AWR) and Strattice underlay from 2007 to 2010. Intermediate-risk patients were defined as having multiple comorbidities without abdominal infection. Forty-one patients met the inclusion criteria (mean age, 60 years; mean body mass index, 35.5 kg/m2). Comorbidities included coronary artery disease (63.4%), diabetes mellitus (36.6%), and chronic obstructive pulmonary disease (17.1%). Fascial closure was achieved in 40 patients (97.6%). Average hospitalization was 6.4 days (range, 1-24 days). Complications included seroma (7.3%), wound dehiscence with Strattice exposure (4.9%), cellulitis (2.4%), and hematoma (2.4%). All patients achieved abdominal wall closure with no recurrent hernias or need for Strattice removal. Patients with multiple comorbidities at intermediate risk of postoperative complications can achieve successful, safe AWR with Strattice.
KW - Abdominal wall reconstruction
KW - Acellular dermal matrix
KW - Comorbidities
KW - Herniorrhaphy
KW - Strattice
UR - http://www.scopus.com/inward/record.url?scp=84896514401&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84896514401&partnerID=8YFLogxK
U2 - 10.9738/INTSURG-D-13-00053.1
DO - 10.9738/INTSURG-D-13-00053.1
M3 - Article
C2 - 24229027
AN - SCOPUS:84896514401
VL - 98
SP - 379
EP - 384
JO - International Surgery
JF - International Surgery
SN - 0020-8868
IS - 4
ER -